Screening and Treatment Reduce Breast Cancer Mortality Screening and Treatment Reduce Breast Cancer Mortality
Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Vid wrapper: Researcher speaks on MyChart Mobile tool with AuntMinnie.com
Researchers recently had results published showing the efficacy of an online tool for women to better understand their breast cancer screening results, including what their mammograms mean.Seetharam Chadalavada, MD, from the University of Cincinnati co-authored the paper, published in the Journal of the American College of Radiology, and spoke with AuntMinnie.com on how a human-centered design framework led to the tool's creation. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Researcher speaks on MyChart Mobile tool with AuntMinnie.com
Researchers recently had results published showing the efficacy of an online tool for women to better understand their breast cancer screening results, including what their mammograms mean.Seetharam Chadalavada, MD, from the University of Cincinnati co-authored the paper, published in the Journal of the American College of Radiology, and spoke with AuntMinnie.com on how a human-centered design framework led to the tool's creation. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Race Can Affect Breast Cancer Test for Predicting Chemo Benefit
TUESDAY, Feb. 6, 2024 -- The 21-gene breast recurrence score (RS) is valid for predicting chemotherapy benefit for non-Hispanic Black (NHB), Hispanic, and non-Hispanic White (NHW) women with estrogen receptor (ER)-positive, axillary node-negative... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2024 Category: Pharmaceuticals Source Type: news
As a breast cancer survivor, I wanted a partner who saw me for more than my missing parts
Opening herself up to dating after breast cancer and reconstructive surgery made Victoria Cassidy vulnerable to heartbreak. But she found her way to love and happiness, with someone who saw her as whole and complete. (Source: CBC | Health)
Source: CBC | Health - February 6, 2024 Category: Consumer Health News Tags: News/Canada/Saskatchewan Source Type: news
Editorial criticizes breast screening guidelines, ACR responds
An editorial criticizing the U.S. Preventive Services Task Force (USPSTF) breast cancer screening guidelines has drawn the ire of the American College of Radiology (ACR). The editorial, published February 5 in the Annals of Internal Medicine, stated that the updated USPSTF guidelines issued in 2023 could create more confusion among women considering undergoing breast cancer screening and make way for more harm tied to screening. “The USPSTF risks abandoning its role in setting the standard for using evidence and sound judgment to make medical decisions,” wrote Russell Harris, MD, a former USPSTF member, in his ed...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Associations Breast Imaging Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
CEM image quality unaffected by iron particles from tracers
Low-dose iron oxide tracers impact the quality of breast MR images, but not that of contrast-enhanced mammography (CEM), a study published February 5 in Surgical Oncology found.
Researchers led by Elisabeth van Haaren from the Zuyderland Medical Centre in Sittard-Geleen, the Netherlands, found that even after a low-dose injection (1 ml) of superparamagnetic iron oxide (SPIO) tracer, iron remnants stay behind in the breast tissue and disturb all MR images. However, they also observed no such effect on CEM images.
“CEM could be valuable alternative if additional imaging is needed in the follow-up of breast cancer,” van...
Source: AuntMinnie.com Headlines - February 6, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Subspecialties MRI Ultrasound Breast Imaging Source Type: news
ChatGPT shows promise for improving breast cancer education materials
ChatGPT can simplify responses to questions about breast cancer prevention and screening by improving the reading ease and readability of educational materials while maintaining overall clinical appropriateness, researchers have found.The findings could translate to better support for patients navigating breast cancer screening, wrote a team led by Hana Haver, MD, of the University of Maryland Medical Intelligent Imaging Center in Baltimore. The study findings were published February 2 in Radiology: Imaging Cancer."In the context of breast cancer screening, increasing the readability of patient-facing material has been sho...
Source: AuntMinnie.com Headlines - February 5, 2024 Category: Radiology Tags: Clinical News Subspecialties Womens Imaging Breast Breast Imaging Source Type: news
Cancer screening hasn't rebounded to prepandemic levels
Preventive health screenings, including those for screening mammography, have not rebounded to pre-COVID-19 pandemic levels, a new study published February 2 in JAMA Health Forum found.
Researchers led by Rishi Wadhera, MD, from Beth Israel Deaconess Medical Center in Boston found that eligible adults were significantly less likely to receive breast cancer screening and other types of health screening in 2021 compared with 2019.
“These findings support the need for public health efforts to increase the use of preventive health screenings among eligible U.S. adults,” Wadhera and co-authors wrote.
Previous research ha...
Source: AuntMinnie.com Headlines - February 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Breast Imaging Source Type: news
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer
(MedPage Today) -- Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology)
Hologic announced FDA clearance of a digital cytology system... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2024 Category: Hematology Source Type: news
Global cancer burden grows as NHS England launches national gene testing programme
Ahead of World Cancer Day on 4 February, the World Health Organization (WHO) has released new figures showing that the global cancer burden is growing. The survey undertaken by the WHO’s cancer agency, the International Agency for Research on Cancer (IARC), shows a growing need for more cancer-related health services worldwide. Figures from 2022 show... Read moreThe post Global cancer burden grows as NHS England launches national gene testing programme appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 1, 2024 Category: Nursing Authors: Carolyn Scott Tags: Cancer BRCA gene testing Breast cancer colorectal cancer lung cancer prostate cancer stomach cancer Source Type: news
Camp Lejeune Water Contamination Tied to a Range of Cancers
NEW YORK — Military personnel stationed at Camp Lejeune from 1975 to 1985 had at least a 20% higher risk for a number of cancers than those stationed elsewhere, federal health officials said Wednesday in a long-awaited study about the North Carolina base’s contaminated drinking water.
Federal health officials called the research one the largest ever done in the United States to assess cancer risk by comparing a group who live and worked in a polluted environment to a similar group that did not.
[time-brightcove not-tgx=”true”]
The study found military personnel stationed at U.S. Marine Corps ...
Source: TIME: Health - February 1, 2024 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate wire Source Type: news
World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2).
In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline
Group salesgrow by 1%1 at constant exchange rates (CER; -7% in CHF), more than offsetting the decline in COVID-19-related sales and biosimilar erosion, and thereby exceeding 2023 guidanceExcluding COVID-19 products,Group sales increase by 8%Pharmaceuticals Divisionsalesincrease by 6% (excluding COVID-19 medicine Ronapreve: +9%) due to ongoing high demand for newer medicines, with eye medicine Vabysmo continuing to be the top growth driver, followed by Ocrevus (multiple sclerosis), Hemlibra (haemophilia A) and Polivy (blood cancer)Diagnostics Division salesare 13% lower due to high demand for COVID-19 tests in 2022; strong ...
Source: Roche Media News - February 1, 2024 Category: Pharmaceuticals Source Type: news
